Assetmark, Inc Pmv Pharmaceuticals, Inc. Transaction History

Assetmark, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Oct 27, 2023	BUY	$6.01 - $8.93 $1,935 - $2,875	322 Added 16.97%	2,220 $13,000
Q2 2023 Aug 11, 2023	BUY	$3.94 - $6.27 $1,804 - $2,871	458 Added 31.81%	1,898 $11,000
Q1 2023 May 05, 2023	BUY	$4.77 - $9.16 $1,836 - $3,526	385 Added 36.49%	1,440 $6,000
Q4 2022 Feb 10, 2023	BUY	$8.17 - $12.95 $2,320 - $3,677	284 Added 36.84%	1,055 $9,000
Q3 2022 Nov 01, 2022	BUY	$11.4 - $17.18 $2,770 - $4,174	243 Added 46.02%	771 $9,000
Q2 2022 Aug 03, 2022	BUY	$9.23 - $22.43 $2,464 - $5,988	267 Added 102.3%	528 $8,000
Q1 2022 May 13, 2022	BUY	$14.86 - $23.55 $3,878 - $6,146	261 New	261 $5,000

41.9M

3.1K

1.7K

Ticker PMVP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,622,600
Market Cap $73.5M
Description
PMV Pharmaceuticals, Inc., a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. The company's lead product candidate is PC14586, a small molecule that corrects a p53 protein containing the Y220C mutation and restores wild-type p53 function. It is also d...

Get notified when there are updates to the investment portfolio of Assetmark, Inc, based on Form 13F filings with the SEC.

Stay updated on Assetmark, Inc with notifications on news.